Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq

Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally, and is a significant contributor to both morbidity and mortality rates. Emerging research has promptly highlighted the potential role of the gut microbiome in the development and progression of CRC. This study aims to inve...

Full description

Saved in:
Bibliographic Details
Main Authors: Fatima J. Kadhim, Zahid S. Aziz, Khalid S. Ibrahim
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Microbiology Research
Subjects:
Online Access:https://www.mdpi.com/2036-7481/16/1/22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587920445276160
author Fatima J. Kadhim
Zahid S. Aziz
Khalid S. Ibrahim
author_facet Fatima J. Kadhim
Zahid S. Aziz
Khalid S. Ibrahim
author_sort Fatima J. Kadhim
collection DOAJ
description Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally, and is a significant contributor to both morbidity and mortality rates. Emerging research has promptly highlighted the potential role of the gut microbiome in the development and progression of CRC. This study aims to investigate the differences in gut microbiota between CRC patients and healthy individuals in Iraq, using 16S rRNA metagenomic sequencing on Illumina NovaSeq (PE250-Seq). A total of 21 stool samples were analyzed: 12 from early-stage CRC patients and nine from healthy controls. Bacterial DNA was extracted, followed by 16S rRNA amplicon sequencing to profile the microbial communities. The results indicated significant differences between the fecal microbiome of the two groups. Remarkably, CRC patients exhibited a marked reduction in Bacteroidota and an increase in Verrucomicrobiota compared to healthy controls. At the genus level, <i>Prevotella</i>, <i>Faecalibacterium</i>, <i>Roseburia</i>, <i>Barnesiella</i>, <i>Eubacterium</i> Lachnospiraceae_UCG_004, and <i>Lachnospira</i> were significantly less abundant in CRC patients compared to the healthy individuals, while <i>Actinomyces</i>, <i>Monoglobus</i>, <i>Desulfovibrio</i>, <i>Akkermansia,</i> and <i>Bacteroides</i> were highly enriched. In addition, diversity analyses further indicated decreased α-diversity and distinct β-diversity patterns in the CRC patients, suggesting significant shifts in the gut microbial composition. These findings underscore the potential of microbiome-based diagnostics and therapeutic strategies, with microbial alterations serving as biomarkers for CRC diagnosis. Further research needs to focus on elucidating the causal relationships and therapeutic potential of these microbiome changes in CRC management.
format Article
id doaj-art-5f45be55e2684279bc7bd5bf06b6d46c
institution Kabale University
issn 2036-7481
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Microbiology Research
spelling doaj-art-5f45be55e2684279bc7bd5bf06b6d46c2025-01-24T13:41:46ZengMDPI AGMicrobiology Research2036-74812025-01-011612210.3390/microbiolres16010022Gut Microbiome Profiles in Colorectal Cancer Patients in IraqFatima J. Kadhim0Zahid S. Aziz1Khalid S. Ibrahim2Department of Biology, College of Science, University of Misan, Maysan 62001, IraqDepartment of Biology, College of Science, University of Misan, Maysan 62001, IraqDepartment of Biology, College of Science, University of Zakho, Duhok 42002, IraqColorectal cancer (CRC) is the third most commonly diagnosed cancer globally, and is a significant contributor to both morbidity and mortality rates. Emerging research has promptly highlighted the potential role of the gut microbiome in the development and progression of CRC. This study aims to investigate the differences in gut microbiota between CRC patients and healthy individuals in Iraq, using 16S rRNA metagenomic sequencing on Illumina NovaSeq (PE250-Seq). A total of 21 stool samples were analyzed: 12 from early-stage CRC patients and nine from healthy controls. Bacterial DNA was extracted, followed by 16S rRNA amplicon sequencing to profile the microbial communities. The results indicated significant differences between the fecal microbiome of the two groups. Remarkably, CRC patients exhibited a marked reduction in Bacteroidota and an increase in Verrucomicrobiota compared to healthy controls. At the genus level, <i>Prevotella</i>, <i>Faecalibacterium</i>, <i>Roseburia</i>, <i>Barnesiella</i>, <i>Eubacterium</i> Lachnospiraceae_UCG_004, and <i>Lachnospira</i> were significantly less abundant in CRC patients compared to the healthy individuals, while <i>Actinomyces</i>, <i>Monoglobus</i>, <i>Desulfovibrio</i>, <i>Akkermansia,</i> and <i>Bacteroides</i> were highly enriched. In addition, diversity analyses further indicated decreased α-diversity and distinct β-diversity patterns in the CRC patients, suggesting significant shifts in the gut microbial composition. These findings underscore the potential of microbiome-based diagnostics and therapeutic strategies, with microbial alterations serving as biomarkers for CRC diagnosis. Further research needs to focus on elucidating the causal relationships and therapeutic potential of these microbiome changes in CRC management.https://www.mdpi.com/2036-7481/16/1/22gut microbiomecolorectal cancerMisanIraq
spellingShingle Fatima J. Kadhim
Zahid S. Aziz
Khalid S. Ibrahim
Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
Microbiology Research
gut microbiome
colorectal cancer
Misan
Iraq
title Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
title_full Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
title_fullStr Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
title_full_unstemmed Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
title_short Gut Microbiome Profiles in Colorectal Cancer Patients in Iraq
title_sort gut microbiome profiles in colorectal cancer patients in iraq
topic gut microbiome
colorectal cancer
Misan
Iraq
url https://www.mdpi.com/2036-7481/16/1/22
work_keys_str_mv AT fatimajkadhim gutmicrobiomeprofilesincolorectalcancerpatientsiniraq
AT zahidsaziz gutmicrobiomeprofilesincolorectalcancerpatientsiniraq
AT khalidsibrahim gutmicrobiomeprofilesincolorectalcancerpatientsiniraq